D. Zimmerman et al., Impaired bone formation in transgenic mice resulting from altered integrinfunction in osteoblasts, DEVELOP BIO, 220(1), 2000, pp. 2-15
To determine the role of integrins in mature osteoblasts in vivo, we expres
sed in transgenic mice a dominant-negative integrin subunit (beta 1-DN) con
sisting of the beta 1 subunit cytoplasmic and transmembrane domains, driven
by the osteoblast-specific osteocalcin promoter. Immature osteoblasts isol
ated ham transgenic animals differentiated normally in vitro until the oste
ocalcin promoter became active; thereafter they detached from the substratu
m, suggesting that beta 1-DN was impairing adhesion in mature osteoblasts.
Transgenic animals had reduced bone mass, with increased cortical porosity
in long bones and thinner hat bones in the skull. At 35 days, the rate of b
one formation was reduced in cortical bone, and the parietal banes were 45%
thinner than in wild-type animals. Active osteoblasts were less polar and
had larger areas of cytoplasm with intracelluar stores of matrix molecules.
Osteocyte lacunae appeared normal around the cell body but did not have no
rmal canilicular structures. At 90 days, the parietal bone of transgenic ma
les was of normal width, suggesting that the original defect in matrix depo
sition had been repaired or compensated for. In contrast, transgenic female
s still had decreased bone mass in the parietal bone at 30 days. The decrea
sed bone mass in TG females was accompanied by increased staining for osteo
clast activity, suggesting that there was a seu-specific defect in mature a
nimals. (C) 2000 Academic Press.